Condition
Lung Cancer (SCLC)
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Not Yet Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07742800Not Yet Recruiting
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
NCT07258147Phase 2Not Yet RecruitingPrimary
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
NCT07442292Not Yet Recruiting
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
NCT07202260Active Not Recruiting
Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung
Showing all 4 trials